Home
>
National Drug Code (NDC)
>
Covera-HS
Covera-HS - 0025-2021-31 - (verapamil hydrochloride)
Drug Information of Covera-HS
| Product NDC: | 0025-2021 |
| Proprietary Name: | Covera-HS |
| Non Proprietary Name: | verapamil hydrochloride |
| Active Ingredient(s): | 240 mg/1 & nbsp; verapamil hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Covera-HS
| Product NDC: | 0025-2021 |
| Labeler Name: | G.D. Searle LLC Division of Pfizer Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020552 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19960226 |
Package Information of Covera-HS
| Package NDC: | 0025-2021-31 |
| Package Description: | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0025-2021-31) |
NDC Information of Covera-HS
| NDC Code | 0025-2021-31 |
| Proprietary Name | Covera-HS |
| Package Description | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0025-2021-31) |
| Product NDC | 0025-2021 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | verapamil hydrochloride |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 19960226 |
| Marketing Category Name | NDA |
| Labeler Name | G.D. Searle LLC Division of Pfizer Inc |
| Substance Name | VERAPAMIL HYDROCHLORIDE |
| Strength Number | 240 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC] |
